Marinus Pharmaceuticals reported $-19507000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
ALKERMES ALKS:US $ -28.99M 31.35M
Amgen AMGN:US $ 1884M 1420M
Aptinyx Inc APTX:US $ -21231000 1.41M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
Biogen BIIB:US $ 329.2M 119.3M
Eisai 4523:JP Y 4024M 38138M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Gilead Sciences GILD:US $ 2592M 1070M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Intra Cellular Therapies ITCI:US $ -76.91M 8.16M
Marinus Pharmaceuticals MRNS:US $ -19.51M 4.32M
Minerva Neurosciences NERV:US $ -9.2M 1.38M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Ptc Therapeutics PTCT:US $ -133.62M 15.25M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Supernus Pharmaceuticals SUPN:US $ 21.56M 2.16M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
YTE INCY:US $ 181.74M 32.28M
Zogenix ZGNX:US $ -58M 0.89M